FDA calls for federal investigation into approval of Biogen’s Alzheimer’s drug

1 Minute Read by Reuters Staff Reuters, July 9 – On Friday, the Food and Drug Administration’s acting commissioner asked for a federal probe of the agency’s approval of Biogen’s Alzheimer’s disease medication. (Manas Mishra in Bengaluru contributed reporting; Arun Koyyur edited the piece.)/nRead More